Quality & complianceOfficial

Greek regulator EOF recalls three batches of Pedmarqsi 80 mg/ml solution for infusion

🇬🇷 EOF · Thu 29 Oct 2026

EOF has announced the recall of batches 467504, 477651 and 484536 of Pedmarqsi infusion solution; the available notice does not give a reason or recall level.

The Greek National Organisation for Medicines (EOF) has announced the recall of three batches of Pedmarqsi 80 mg/ml, a solution for infusion. The affected batch numbers are 467504, 477651 and 484536.

The announcement is filed under protocol number 129911 and is dated 29 October 2026. The text available to VigiEye is brief and points readers to a linked decision for the full details.

That text does not say why the batches are being recalled, nor does it specify the recall level, such as wholesaler, pharmacy or patient level. It also gives no details on the marketing authorisation holder or on instructions for returning stock.

As general context, a batch recall obliges the supply chain to stop distributing or dispensing the named lots, and usually to quarantine and return them as the competent authority directs.

What it means for your team

  • Check the full EOF decision linked from protocol no. 129911 for the reason, recall level and any return instructions before acting.
  • Identify and quarantine any stock of Pedmarqsi 80 mg/ml from batches 467504, 477651 and 484536 held in Greece, pending guidance.
  • Quality and pharmacovigilance teams should confirm whether the batches were distributed elsewhere and whether any related reports or complaints need review.

Official source: EOF ↗

Article written by VigiEye from the official source (EOF). AI-assisted; check the source before acting.

More Quality & compliance All →